Skip to main content
. 2022 Dec 21;18(9):2215–2219. doi: 10.1111/jth.15016

Table 1.

Patient characteristics and laboratory results

ICU Non‐ICU P
Patients, n 48 30
Age, y 62.8 ± 13.1 60.2 ± 14.6 .39
BMI, kg/m2 29 ± 5.5 26.2 ± 4.8 .07
SOFA score 5.4 ± 3.1
SAPS II score 37.9 ± 13
Fibrinogen, g/L (normal values = 2‐4) 6.1 ± 1.9 5.6 ± 1.7 .38
FVIII, % (normal values = 50‐150) 199 ± 65 160 ± 28 .22
Antithrombin, % (normal values = 80‐120) 87 ± 28 106 ± 14 .016
D‐dimers, ng/mL (normal values < 500) 3456 ± 2641 874 ± 539 .0019
Peak thrombin, nM (normal values = 350 ± 39) 312 ± 127 391 ± 76 .004
ETP, nM/min (normal values = 1593 ± 206) 1682 ± 610 1815 ± 357 .31
t‐PA, ng/mL (normal values = 2‐12) 23.9 ± 14.5 14.4 ± 7.5 <.0001
PAI‐1, ng/mL (normal values = 4‐43) 96.3 ± 35 76.8 ± 40 .017
TAFIa/i, ng/mL (normal values = 1.76‐28.9) 60.2 ± 42.3 39.8 ± 23.8 .016
Alpha 2 antiplasmin, UI/dL (normal values = 80‐120) 124.6 ± 15.8 128 ± 9.2 .41
Patients, n 19 4
TEM‐tPA MCF, mm (normal values = 32 ± 10.4) 62.3 ± 10 61.5 ± 6.5 .69
TEM‐tPA alpha angle, (normal values = 69 ± 5) 81 ± 1.4 79 ± 2.3 .065
Ly30, % (normal values = 1.8 ± 3.2) 63 ± 39 18 ± 35 .022

BMI, body mass index; SAPS II, Simplified Acute Physiology Score; SOFA, sequential organ failure assessment.